definiens: as defined under this Section 5.9.3 is an alternative arrangement consisting of one ormore of the following : ( i ) an arrangement ( to be facilitated by Ventana acting in good faith)whereby Blueprint may distribute the Ventana IVD in a country or countries in therelevant Markets and have the right to purchase from Ventana or its Divisional Affiliatesthe necessary quantities of Ventana IVD at a commercially reasonable price, ( ii ) anarrangement whereby a Third Party may distribute the Ventana IVD in a country orcountries in the relevant Markets, ( iii ) an arrangement to transport tissue samples tocountries in the relevant Markets where the Ventana IVD is available, ( iv ) a licensingarrangement whereby Blueprint may use, make, have made, sell, offer for sale, import orotherwise exploit the Ventana IVD or an alternative product to the Ventana IVD for usewith the Blueprint Product in a country or countries, ( v ) [ … * * * … ], ( vi ) supplying theantibodies, reagents ( except for those reagents that are part of the Ventana proprietarydetection systems ) and the Know - How that may be useful or necessary for Blueprint ora Third Party to develop an alternative product to the Ventana IVD, including in suchquantities as reasonably required by Blueprint for development and Commercializationpurposes, and providing such assistance as is reasonably requested by Blueprint,(vii ) enabling a Laboratory Developed Test at a mutually acceptable laboratory ( to theextent such alternative arrangement would meet Blueprint ’s needs consistent withApplicable Law ), ( viii ) enabling a PMA Laboratory Developed Test at a mutuallyacceptable laboratory ( to the extent such alternative arrangement would meet Blueprint’sneeds consistent with Applicable Law ), or ( ix ) [ … * * * … ], or ( x ) such other mutuallyagreeable arrangement to help support sales of the Blueprint Product, with the ultimategoal of ensuring that diagnostic testing using the Ventana IVD in connection with theBlueprint Product is ( or remains ) available in the countries in the relevant Markets asreasonably practicable